Mallinckrodt Pharmaceuticals

URI: https://gptkb.org/entity/Mallinckrodt_Pharmaceuticals
GPTKB entity
Statements (32)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Cadence_Pharmaceuticals
gptkb:Questcor_Pharmaceuticals
gptkbp:containsSettlement $1.6 billion (opioid litigation)
gptkbp:countryOfOrigin gptkb:United_States
gptkbp:filedForBankruptcy 2020
2023
gptkbp:founded 1867
gptkbp:founder gptkb:Gustav_Mallinckrodt
gptkbp:headquartersLocation gptkb:Staines-upon-Thames,_United_Kingdom
gptkb:Hazelwood,_Missouri,_United_States
https://www.w3.org/2000/01/rdf-schema#label Mallinckrodt Pharmaceuticals
gptkbp:industry pharmaceuticals
gptkbp:legalIssue opioid litigation
gptkbp:notableProduct gptkb:Acthar_Gel
gptkb:INOMAX
gptkb:Ofirmev
gptkbp:numberOfEmployees ~3,400 (2023)
gptkbp:parentCompany gptkb:Mallinckrodt_plc
gptkbp:products generic drugs
contrast media
specialty pharmaceuticals
gptkbp:reorganizedAs 2022
gptkbp:stockExchangeDelisted gptkb:NYSE
gptkbp:stockSymbol gptkb:MNK_(formerly)
gptkbp:tradedOn NYSE: MNK (formerly)
gptkbp:type gptkb:public_company
gptkbp:website https://www.mallinckrodt.com/
gptkbp:bfsParent gptkb:Mallinckrodt_Chemical_Works
gptkb:PhRMA
gptkb:Methylin
gptkbp:bfsLayer 6